Comparison of The Efficacy of Letrozole Versus Danazol in Pain Relief in Endometriosis
Efficacy of Letrozole and Danazol in Endometriosis
DOI:
https://doi.org/10.54393/pjhs.v3i06.345Keywords:
Endometriosis, Danazol, Letrozole, Pelvic Pain.Abstract
Endometriosis is a chronic inflammatory disease defined as the presence of endometrium-like tissue outside the uterus which is responsive to the estrogen levels in blood circulation. Objective: To compare the efficacy of letrozole versus danazol in pain relief in endometriosis. Methods: This randomized controlled trial was conducted at the department of Obstetrics & Gynecology, Ayub Teaching Hospital, Abbottabad, Pakistan from January 2018 to December 2021. Patients diagnosed with endometriosis were enrolled and detailed medical history was taken. Patients were randomly divided into either Letrozole (n=120) or Danazol (n=120) group. Both treatment groups were evaluated after 3 months of treatment and efficacy was compared in terms of pain relief in patients of endometriosis. Results: In a total of 240 patients, the mean age was 28.30±4.76 years. The mean endometrial cyst size was 2.48±1.14 cm. At baseline, mean visual analog scale (VAS) score was recorded as 5.46±1.09 points in letrozole group and 5.28±1.01 points in danazol group (p=0.186). After three months of treatment, the mean VAS score was 2.94±1.96 points in letrozole group and 3.99±1.90 points in danazol group (p=0.002). Relief of symptoms was observed in 114 (47.5%) women and more patients reported relief of symptoms in letrozole group (65 patients) than the danazol group (49 patients) (p=0.039). Conclusion: Letrozole was more effective as compare to danazol in relief of pain in patients with endometriosis
References
Kim SH, Chae HD, Kim CH, Kang BM. Update on the treatment of endometriosis. Clinical and experimental reproductive medicine. 2013 Jun; 40(2):55. doi: 10.5653/cerm.2013.40.2.55
Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, et al. ESHRE guideline: endometriosis. Human reproduction open. 2022; 2022(2): hoac009. doi: 10.1093/hropen/hoac009
Kuznetsov L, Dworzynski K, Davies M, Overton C. Diagnosis and management of endometriosis: summary of NICE guidance. Bmj. 2017 Sep; 358. doi: 10.1136/bmj.j3935
Madny EH. Efficacy of letrozole in treatment of endometriosis-related pain. Middle East Fertility Society Journal. 2014 Mar; 19(1):64-8. doi: 10.1016/j.mefs.2013.04.007
Morotti M, Vincent K, Becker CM. Mechanisms of pain in endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2017 Feb; 209: 8-13. doi: 10.1016/j.ejogrb.2016.07.497
Maddern J, Grundy L, Castro J, Brierley SM. Pain in endometriosis. Frontiers in Cellular Neuroscience. 2020 Oct 6; 14: 590823. doi: 10.3389/fncel.2020.590823
Stratton P, Khachikyan I, Sinaii N, Ortiz R, Shah J. Association of chronic pelvic pain and endometriosis with signs of sensitization and myofascial pain. Obstetrics and gynecology. 2015 Mar; 125(3): 719. doi: 10.1097/AOG.0000000000000663
Zhao Y, Gong P, Chen Y, Nwachukwu JC, Srinivasan S, Ko C, Bagchi MK, et al. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Science translational medicine. 2015 Jan; 7(271): 271ra9. doi: 10.1126/scitranslmed.3010626
Garzon S, Laganà AS, Barra F, Casarin J, Cromi A, Raffaelli R, et al. Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development. Expert Opinion on Investigational Drugs. 2020 Dec; 29(12): 1377-88.doi: 10.1080/13543784.2020.1842356
Bedaiwy MA, Allaire C, Yong P, Alfaraj S. Medical management of endometriosis in patients with chronic pelvic pain. InSeminars in reproductive medicine 2017 Jan; 35(1): 038-053. Thieme Medical Publishers. doi: 10.1055/s-0036-1597308
Stauffer F, Furet P, Floersheimer A, Lang M. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo [2, 3-c] pyridine series. Bioorganic & medicinal chemistry letters. 2012 Mar; 22(5): 1860-3. doi: 10.1016/j.bmcl.2012.01.076
Ferrero S, Gillott DJ, Venturini PL, Remorgida V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reproductive Biology and Endocrinology. 2011 Dec; 9(1):1-0. doi: 10.1186/1477-7827-9-89
Rasul SG, Yaqub U, Manzoor M, Mubasshar H. Comparison of Letrozole versus Danazol for the Pain Management of Females Presented with Endometriosis. Annals of King Edward Medical University. 2017 Oct; 23(4): 514-8. doi: 10.21649/akemu.v23i4.2231
Roghaei MA, Ghasemi Tehrany H, Taherian A, Koleini N. Effects of letrozole compared with danazol on patients with confirmed endometriosis: a randomized clinical trial. International Journal of Fertility and Sterility. 2010 Jul; 4(2): 67-72. https://dx.doi.org/10.22074/ijfs.2010.45826
Almassinokiani F, Almasi A, Akbari P, Saberifard M. Effect of Letrozole on endometriosis-related pelvic pain. Medical Journal of the Islamic Republic of Iran. 2014; 28: 107.
Barra F, Scala C, Mais V, Guerriero S, Ferrero S. Investigational drugs for the treatment of endometriosis, an update on recent developments. Expert opinion on investigational drugs. 2018 May; 27(5): 445-58. doi: 10.1080/13543784.2018.1471135
Goenka L, George M, Sen M. A peek into the drug development scenario of endometriosis–A systematic review. Biomedicine & Pharmacotherapy. 2017 Jun; 90: 575-85. doi: 10.1016/j.biopha.2017.03.092
Badawy AM, Elnashar AM, Mosbah AA. Aromatase inhibitors or gonadotropin‐releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica. 2012 Apr; 91(4): 489-95. doi: 10.1111/j.1600-0412.2012.01350.x
Seal SL, Kamilya G, Mukherji J, De A, Ghosh D, Majhi AK. Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review. Fertility and sterility. 2011 Jan; 95(1): 291-e15. doi: 10.1016/j.fertnstert.2010.05.021
Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertility and sterility. 2004 Feb; 81(2): 290-6. doi: 10.1016/j.fertnstert.2003.09.029
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
